Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures

INTRODUCTION A recombinant form of activated factor VII (rFVIIa) is a haemostatic drug that is approved for use in haemophiliacs with antibodies to factor VIII or factor IX. Most recent studies and clinical experience have shown that rFVIIa (NovoSeven ®, Novo Nordisk A/S, Denmark) gives extreme haem...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Končar Igor B., Savić Nebojša, Davidović Lazar B., Simić Dušica, Marković Dejan, Sinđelić Radomir B.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Serbian Medical Society 2008-01-01
coleção:	Srpski Arhiv za Celokupno Lekarstvo
Assuntos:	recombinant activated factor VII (rFVIIa) intractablenon-surgical bleeding vascular surgery
Acesso em linha:	http://www.doiserbia.nb.rs/img/doi/0370-8179/2008/0370-81790808367K.pdf
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!